Ethel S Gilbert1. 1. Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA. gilberte@mail.nih.gov
Abstract
PURPOSE: Epidemiologic studies of persons exposed to ionising radiation offer a wealth of information on cancer risks in humans. The Life Span Study cohort of Japanese A-bomb survivors, a large cohort that includes all ages and both sexes with a wide range of well-characterised doses, is the primary resource for estimating carcinogenic risks from low linear energy transfer external exposure. Extensive data on persons exposed for therapeutic or diagnostic medical reasons offer the opportunity to study fractionated exposure, risks at high therapeutic doses, and risks of site-specific cancers in non-Japanese populations. Studies of persons exposed for occupational and environmental reasons allow a direct evaluation of exposure at low doses and dose rates, and also provide information on different types of radiation such as radon and iodine-131. This article summarises the findings from these studies with emphasis on studies with well-characterised doses. CONCLUSIONS: Epidemiologic studies provide the necessary data for quantifying cancer risks as a function of dose and for setting radiation protection standards. Leukaemia and most solid cancers have been linked with radiation. Most solid cancer data are reasonably well described by linear-dose response functions although there may be a downturn in risks at very high doses. Persons exposed early in life have especially high relative risks for many cancers, and radiation-related risk of solid cancers appears to persist throughout life.
PURPOSE: Epidemiologic studies of persons exposed to ionising radiation offer a wealth of information on cancer risks in humans. The Life Span Study cohort of Japanese A-bomb survivors, a large cohort that includes all ages and both sexes with a wide range of well-characterised doses, is the primary resource for estimating carcinogenic risks from low linear energy transfer external exposure. Extensive data on persons exposed for therapeutic or diagnostic medical reasons offer the opportunity to study fractionated exposure, risks at high therapeutic doses, and risks of site-specific cancers in non-Japanese populations. Studies of persons exposed for occupational and environmental reasons allow a direct evaluation of exposure at low doses and dose rates, and also provide information on different types of radiation such as radon and iodine-131. This article summarises the findings from these studies with emphasis on studies with well-characterised doses. CONCLUSIONS: Epidemiologic studies provide the necessary data for quantifying cancer risks as a function of dose and for setting radiation protection standards. Leukaemia and most solid cancers have been linked with radiation. Most solid cancer data are reasonably well described by linear-dose response functions although there may be a downturn in risks at very high doses. Persons exposed early in life have especially high relative risks for many cancers, and radiation-related risk of solid cancers appears to persist throughout life.
Authors: Michele Morin Doody; D Michal Freedman; Bruce H Alexander; Michael Hauptmann; Jeremy S Miller; R Sowmya Rao; Kiyohiko Mabuchi; Elaine Ron; Alice J Sigurdson; Martha S Linet Journal: Cancer Date: 2006-06-15 Impact factor: 6.860
Authors: E Cardis; M Vrijheid; M Blettner; E Gilbert; M Hakama; C Hill; G Howe; J Kaldor; C R Muirhead; M Schubauer-Berigan; T Yoshimura; F Bermann; G Cowper; J Fix; C Hacker; B Heinmiller; M Marshall; I Thierry-Chef; D Utterback; Y-O Ahn; E Amoros; P Ashmore; A Auvinen; J-M Bae; J Bernar Solano; A Biau; E Combalot; P Deboodt; A Diez Sacristan; M Eklof; H Engels; G Engholm; G Gulis; R Habib; K Holan; H Hyvonen; A Kerekes; J Kurtinaitis; H Malker; M Martuzzi; A Mastauskas; A Monnet; M Moser; M S Pearce; D B Richardson; F Rodriguez-Artalejo; A Rogel; H Tardy; M Telle-Lamberton; I Turai; M Usel; K Veress Journal: BMJ Date: 2005-06-29
Authors: R E Curtis; J D Boice; M Stovall; L Bernstein; E Holowaty; S Karjalainen; F Langmark; P C Nasca; A G Schwartz; M J Schymura Journal: J Natl Cancer Inst Date: 1994-09-07 Impact factor: 13.506
Authors: David B Richardson; Steve Wing; Jane Schroeder; Inge Schmitz-Feuerhake; Wolfgang Hoffmann Journal: Environ Health Perspect Date: 2005-01 Impact factor: 9.031
Authors: Daphnée Villoing; R Craig Yoder; Christopher Passmore; Marie-Odile Bernier; Cari M Kitahara Journal: Radiology Date: 2018-02-01 Impact factor: 11.105
Authors: Daphnée Villoing; Cari M Kitahara; Christopher Passmore; Steven L Simon; R Craig Yoder Journal: J Radiol Prot Date: 2018-06-19 Impact factor: 1.394
Authors: Hongping Yu; Hui Zhao; Li-E Wang; Younghun Han; Wei V Chen; Christopher I Amos; Thorunn Rafnar; Patrick Sulem; Kari Stefansson; Maria Teresa Landi; Neil Caporaso; Demetrius Albanes; Michael Thun; James D McKay; Paul Brennan; Yufei Wang; Richard S Houlston; Margaret R Spitz; Qingyi Wei Journal: DNA Repair (Amst) Date: 2011-02-05
Authors: Evagelia C Laiakis; Evan L Pannkuk; Maria Elena Diaz-Rubio; Yi-Wen Wang; Tytus D Mak; Cynthia M Simbulan-Rosenthal; David J Brenner; Albert J Fornace Journal: Mutat Res Date: 2016-03-25 Impact factor: 2.433
Authors: Miriam E Van Dyke; Vladimir Drozdovitch; Michele M Doody; Hyeyeun Lim; Norman E Bolus; Steven L Simon; Bruce H Alexander; Cari M Kitahara Journal: Health Phys Date: 2016-07 Impact factor: 1.316
Authors: Luís Antunes; Maria José Bento; Manuel Sobrinho-Simões; Paula Soares; Paula Boaventura Journal: Br J Radiol Date: 2019-11-11 Impact factor: 3.039